Payment overview · 2025
General Payments
$23.52
1 reported records · 1 companies
Healthcare provider profile · identity verified
Cesar Leonel Goya
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · MIAMI, FL · NPI 1326552431
Verified facts
What the public records show
CMS Open Payments records show Cesar Leonel Goya received $23.52 in general payments during 2025 across 1 reported records.
Sumitomo Pharma America, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Sumitomo Pharma America, Inc. | Unresolved — no canonical attribution shown | $23.52 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $23.52 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| GEMTESA Normalized: gemtesa |
Drug | Sumitomo Pharma America, Inc. | $23.52 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1114 | 348 |
| Metformin Hcl | Metformin Hcl | 668 | 200 |
| Gabapentin | Gabapentin | 627 | 179 |
| Losartan Potassium | Losartan Potassium | 551 | 168 |
| Omeprazole | Omeprazole | 481 | 145 |
| Levothyroxine Sodium | Levothyroxine Sodium | 478 | 128 |
| Lisinopril | Lisinopril | 436 | 130 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 365 | 124 |
| Amlodipine Besylate | Amlodipine Besylate | 361 | 105 |
| Hydrochlorothiazide | Hydrochlorothiazide | 338 | 97 |
| Pantoprazole Sodium | Pantoprazole Sodium | 329 | 98 |
| Fluticasone Propionate | Fluticasone Propionate | 328 | 97 |
| Famotidine | Famotidine | 322 | 94 |
| Montelukast Sodium | Montelukast Sodium | 303 | 97 |
| Diclofenac Sodium | Diclofenac Sodium | 299 | 109 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 294 | 73 |
| Alcohol Prep Pads | Alcohol Antiseptic Pads | 290 | 91 |
| Metoprolol Succinate | Metoprolol Succinate | 283 | 85 |
| Tamsulosin Hcl | Tamsulosin Hcl | 278 | 87 |
| Alendronate Sodium | Alendronate Sodium | 253 | 69 |
| Simvastatin | Simvastatin | 211 | 64 |
| Metoprolol Tartrate | Metoprolol Tartrate | 209 | 53 |
| Eliquis | Apixaban | 200 | 37 |
| Glipizide | Glipizide | 191 | 56 |
| Carvedilol | Carvedilol | 171 | 46 |
| Azithromycin | Azithromycin | 169 | 144 |
| Escitalopram Oxalate | Escitalopram Oxalate | 166 | 51 |
| Ketoconazole | Ketoconazole | 159 | 41 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 156 | 54 |
| Memantine Hcl | Memantine Hcl | 149 | 49 |
| Meclizine Hcl | Meclizine Hcl | 142 | 55 |
| Clopidogrel | Clopidogrel Bisulfate | 141 | 41 |
| Furosemide | Furosemide | 140 | 36 |
| Trazodone Hcl | Trazodone Hcl | 137 | 40 |
| Enalapril Maleate | Enalapril Maleate | 135 | 39 |
| Ammonium Lactate | Ammonium Lactate | 132 | 39 |
| Latanoprost | Latanoprost | 128 | 27 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 128 | 39 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 121 | 22 |
| Ciclopirox | Ciclopirox | 120 | 42 |
| Ibuprofen | Ibuprofen | 120 | 60 |
| Januvia | Sitagliptin Phosphate | 120 | 27 |
| Atenolol | Atenolol | 114 | 32 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 110 | 23 |
| Donepezil Hcl | Donepezil Hcl | 109 | 35 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 109 | 55 |
| Meloxicam | Meloxicam | 106 | 71 |
| Dicyclomine Hcl | Dicyclomine Hcl | 99 | 33 |
| Mirtazapine | Mirtazapine | 94 | 32 |
| Symbicort | Budesonide/Formoterol Fumarate | 93 | 16 |
| Clobetasol Propionate | Clobetasol Propionate | 89 | 25 |
| Irbesartan | Irbesartan | 89 | 27 |
| Comfort Ez Pen Needle | Pen Needle, Diabetic | 86 | 27 |
| Alcohol Swabs | Alcohol Antiseptic Pads | 84 | 38 |
| Chlorthalidone | Chlorthalidone | 81 | 21 |
| Ciclopirox | Ciclopirox Olamine | 81 | 20 |
| Ozempic | Semaglutide | 81 | 12 |
| Linzess | Linaclotide | 75 | 16 |
| Buspirone Hcl | Buspirone Hcl | 72 | 20 |
| Glimepiride | Glimepiride | 71 | 21 |
| Allopurinol | Allopurinol | 70 | 21 |
| Ezetimibe | Ezetimibe | 70 | 22 |
| Alprazolam | Alprazolam | 68 | 19 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 67 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 66 | 17 |
| Finasteride | Finasteride | 64 | 20 |
| Hydralazine Hcl | Hydralazine Hcl | 64 | 18 |
| Methocarbamol | Methocarbamol | 64 | 48 |
| Sertraline Hcl | Sertraline Hcl | 63 | 19 |
| Glipizide Er | Glipizide | 59 | 14 |
| Nitroglycerin | Nitroglycerin | 57 | 13 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 55 | 15 |
| Farxiga | Dapagliflozin Propanediol | 55 | 15 |
| Clonazepam | Clonazepam | 54 | 22 |
| Prednisone | Prednisone | 54 | 33 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 52 | 15 |
| Cilostazol | Cilostazol | 49 | 13 |
| Dexlansoprazole Dr | Dexlansoprazole | 49 | suppressed |
| Temazepam | Temazepam | 48 | 13 |
| Clonidine Hcl | Clonidine Hcl | 47 | 11 |
| Pentoxifylline | Pentoxifylline | 46 | 16 |
| Xarelto | Rivaroxaban | 46 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 45 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 44 | 18 |
| Chlordiazepoxide Hcl | Chlordiazepoxide Hcl | 43 | 15 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 43 | 14 |
| Tradjenta | Linagliptin | 42 | suppressed |
| Vascepa | Icosapent Ethyl | 42 | 12 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 40 | 39 |
| Methotrexate | Methotrexate Sodium | 39 | suppressed |
| Entresto | Sacubitril/Valsartan | 38 | 13 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 38 | 14 |
| Metronidazole | Metronidazole | 38 | 22 |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 38 | 33 |
| Oxybutynin Chloride | Oxybutynin Chloride | 38 | 17 |
| Acyclovir | Acyclovir | 36 | 16 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 36 | 25 |
| Zolpidem Tartrate | Zolpidem Tartrate | 36 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 35 | 29 |
| Duloxetine Hcl | Duloxetine Hcl | 34 | 12 |
| Gemfibrozil | Gemfibrozil | 34 | 13 |
| Paroxetine Hcl | Paroxetine Hcl | 34 | 11 |
| Nifedipine Er | Nifedipine | 33 | 14 |
| Propranolol Hcl | Propranolol Hcl | 33 | suppressed |
| Spironolactone | Spironolactone | 33 | 13 |
| Pregabalin | Pregabalin | 32 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 31 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 31 | suppressed |
| Jardiance | Empagliflozin | 31 | suppressed |
| Timolol Maleate | Timolol Maleate | 31 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 30 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 30 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 29 | 19 |
| Mupirocin | Mupirocin | 29 | 23 |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 28 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 28 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | suppressed |
| Clorazepate Dipotassium | Clorazepate Dipotassium | 27 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 27 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 27 | 11 |
| Mupirocin | Mupirocin Calcium | 27 | 16 |
| Sucralfate | Sucralfate | 27 | suppressed |
| Valsartan | Valsartan | 27 | suppressed |
| Baclofen | Baclofen | 26 | 12 |
| Nystatin | Nystatin | 26 | 11 |
| Colchicine | Colchicine | 25 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 24 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 23 | suppressed |
| Lorazepam | Lorazepam | 23 | suppressed |
| Naproxen | Naproxen | 23 | 13 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 22 | suppressed |
| Amoxicillin | Amoxicillin | 22 | 21 |
| Bupropion Xl | Bupropion Hcl | 22 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 21 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 21 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 21 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 20 | suppressed |
| Lansoprazole | Lansoprazole | 20 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 20 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Dutasteride | Dutasteride | 18 | suppressed |
| Ranolazine Er | Ranolazine | 18 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 18 | 14 |
| Candesartan Cilexetil | Candesartan Cilexetil | 17 | suppressed |
| Fenofibrate | Fenofibrate | 17 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 17 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 17 | 14 |
| Amiodarone Hcl | Amiodarone Hcl | 16 | suppressed |
| Celecoxib | Celecoxib | 16 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Nadolol | Nadolol | 16 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 16 | suppressed |
| Telmisartan | Telmisartan | 15 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 14 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 14 | suppressed |
| Methylprednisolone | Methylprednisolone | 14 | suppressed |
| Mometasone Furoate | Mometasone Furoate | 14 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Synjardy | Empagliflozin/Metformin Hcl | 14 | suppressed |
| Synthroid | Levothyroxine Sodium | 14 | suppressed |
| Tobramycin | Tobramycin | 14 | 12 |
| Cephalexin | Cephalexin | 13 | 13 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 13 | 11 |
| Etodolac | Etodolac | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Hydrocortisone | Hydrocortisone | 13 | suppressed |
| Terbinafine Hcl | Terbinafine Hcl | 13 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 12 | suppressed |
| Clonidine | Clonidine | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Levetiracetam | Levetiracetam | 12 | suppressed |
| Mounjaro | Tirzepatide | 12 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 12 | 11 |
| Repaglinide | Repaglinide | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 11 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 11 | suppressed |
| Jentadueto | Linagliptin/Metformin Hcl | 11 | suppressed |
| Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 11 | suppressed |
| Novolog Flexpen | Insulin Aspart | 11 | suppressed |
| Nucala | Mepolizumab | 11 | suppressed |
| Ofloxacin | Ofloxacin | 11 | suppressed |
| Restasis | Cyclosporine | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $23.52 · 1 records | Sumitomo Pharma America, Inc. | GEMTESA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error